EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | 2C33H37N5O5.C4H6O6 |
| Net Charge | 0 |
| Average Mass | 1317.464 |
| Monoisotopic Mass | 1316.57538 |
| SMILES | O=C(O)[C@H](O)[C@@H](O)C(=O)O.[H][C@@]12Cc3cnc4cccc(c34)[C@@]1([H])C[C@@H](C(=O)N[C@]1(C)O[C@]3(O)N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1CCC[C@]13[H])CN2C.[H][C@@]12Cc3cnc4cccc(c34)[C@@]1([H])C[C@@H](C(=O)N[C@]1(C)O[C@]3(O)N(C1=O)[C@@H](Cc1ccccc1)C(=O)N1CCC[C@]13[H])CN2C |
| InChI | InChI=1S/2C33H37N5O5.C4H6O6/c2*1-32(35-29(39)21-15-23-22-10-6-11-24-28(22)20(17-34-24)16-25(23)36(2)18-21)31(41)38-26(14-19-8-4-3-5-9-19)30(40)37-13-7-12-27(37)33(38,42)43-32;5-1(3(7)8)2(6)4(9)10/h2*3-6,8-11,17,21,23,25-27,34,42H,7,12-16,18H2,1-2H3,(H,35,39);1-2,5-6H,(H,7,8)(H,9,10)/t2*21-,23-,25-,26+,27+,32-,33+;1-,2-/m111/s1 |
| InChIKey | AYYQJUDESMECLY-QCMZQTNXSA-N |
| Roles Classification |
|---|
| Biological Roles: | non-narcotic analgesic A drug that has principally analgesic, antipyretic and anti-inflammatory actions. Non-narcotic analgesics do not bind to opioid receptors. serotonergic agonist An agent that has an affinity for serotonin receptors and is able to mimic the effects of serotonin by stimulating the physiologic activity at the cell receptors. Serotonin agonists are used as antidepressants, anxiolytics, and in the treatment of migraine disorders. |
| Applications: | non-narcotic analgesic A drug that has principally analgesic, antipyretic and anti-inflammatory actions. Non-narcotic analgesics do not bind to opioid receptors. serotonergic agonist An agent that has an affinity for serotonin receptors and is able to mimic the effects of serotonin by stimulating the physiologic activity at the cell receptors. Serotonin agonists are used as antidepressants, anxiolytics, and in the treatment of migraine disorders. vasoconstrictor agent Drug used to cause constriction of the blood vessels. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| dihydroergotamine tartrate (CHEBI:59757) has part dihydroergotamine (CHEBI:4562) |
| dihydroergotamine tartrate (CHEBI:59757) has role non-narcotic analgesic (CHEBI:35481) |
| dihydroergotamine tartrate (CHEBI:59757) has role serotonergic agonist (CHEBI:35941) |
| dihydroergotamine tartrate (CHEBI:59757) has role vasoconstrictor agent (CHEBI:50514) |
| dihydroergotamine tartrate (CHEBI:59757) is a tartrate salt (CHEBI:50562) |
| IUPAC Name |
|---|
| Bis[(10αH)-5'α-benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxo-9,10-dihydroergotaman] (2R,3R)-2,3-dihydroxybutanedioate |
| Synonyms | Source |
|---|---|
| dihydroergotamine (R,R)-tartrate | ChEBI |
| 9,10-dihydroergotamine tartrate | ChemIDplus |
| bis(5'α-benzyl-9,10α-dihydro-12'-hydroxy-2'-methylergotaman-3',6',18-trione) (R-(R*,R*))-tartrate | ChemIDplus |
| 9,10-dihydroergotamine L-tartrate | ChEBI |
| dihydroergotamine L-tartrate | ChEBI |
| 9,10-dihydroergotamine (R,R)-tartrate | ChEBI |